Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Oct 1;351(Pt 1):87–93. doi: 10.1042/0264-6021:3510087

p53 protein oxidation in cultured cells in response to pyrrolidine dithiocarbamate: a novel method for relating the amount of p53 oxidation in vivo to the regulation of p53-responsive genes.

H H Wu 1, J A Thomas 1, J Momand 1
PMCID: PMC1221338  PMID: 10998350

Abstract

A novel method was developed to determine the oxidation status of proteins in cultured cells. Methoxy-polyethylene glycol-maleimide MW 2000 (MAL-PEG) was used to covalently tag p53 protein that was oxidized at cysteine residues in cultured cells. Treatment of MCF7 breast cancer cells with pyrrolidine dithiocarbamate (PDTC), a metal chelator, resulted in a minimum of 25% oxidation of p53. The oxidized p53 had an average of one cysteine residue oxidized per p53 protein molecule. The effect of PDTC treatment on downstream components of the p53 signal-transduction pathway was tested. PDTC treatment prevented actinomycin D-mediated up-regulation of two p53 effector gene products, murine double minute clone 2 oncoprotein and p21(WAF1/CIP1) (where WAF1 corresponds to wild-type p53-activated fragment 1 and CIP1 corresponds to cyclin-dependent kinase-interacting protein 1). Actinomycin D treatment led to accumulation of p53 protein in the nucleus. However, when cells were simultaneously treated with PDTC and actinomycin D, p53 accumulated in both the nucleus and the cytoplasm. The data indicate that an average of one cysteine residue per p53 protein molecule is highly sensitive to oxidation and that p53 can be efficiently oxidized by PDTC in cultured cells. PDTC-mediated oxidation of p53 correlates with altered p53 subcellular localization and reduced activation of p53 downstream effector genes. The novel method for detecting protein oxidation detailed in the present study may be used to determine the oxidation status of specific proteins in cells.

Full Text

The Full Text of this article is available as a PDF (194.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allain P., Krari N. Diethyldithiocarbamate, copper and neurological disorders. Life Sci. 1991;48(3):291–299. doi: 10.1016/0024-3205(91)90357-h. [DOI] [PubMed] [Google Scholar]
  2. Burkitt M. J., Bishop H. S., Milne L., Tsang S. Y., Provan G. J., Nobel C. S., Orrenius S., Slater A. F. Dithiocarbamate toxicity toward thymocytes involves their copper-catalyzed conversion to thiuram disulfides, which oxidize glutathione in a redox cycle without the release of reactive oxygen species. Arch Biochem Biophys. 1998 May 1;353(1):73–84. doi: 10.1006/abbi.1998.0618. [DOI] [PubMed] [Google Scholar]
  3. Casso D., Beach D. A mutation in a thioredoxin reductase homolog suppresses p53-induced growth inhibition in the fission yeast Schizosaccharomyces pombe. Mol Gen Genet. 1996 Oct 16;252(5):518–529. doi: 10.1007/BF02172398. [DOI] [PubMed] [Google Scholar]
  4. Chehab N. H., Malikzay A., Appel M., Halazonetis T. D. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 2000 Feb 1;14(3):278–288. [PMC free article] [PubMed] [Google Scholar]
  5. Chehab N. H., Malikzay A., Stavridi E. S., Halazonetis T. D. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13777–13782. doi: 10.1073/pnas.96.24.13777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chen L., Agrawal S., Zhou W., Zhang R., Chen J. Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage. Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):195–200. doi: 10.1073/pnas.95.1.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chen Q. M., Bartholomew J. C., Campisi J., Acosta M., Reagan J. D., Ames B. N. Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication. Biochem J. 1998 May 15;332(Pt 1):43–50. doi: 10.1042/bj3320043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Craig A. L., Burch L., Vojtesek B., Mikutowska J., Thompson A., Hupp T. R. Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers. Biochem J. 1999 Aug 15;342(Pt 1):133–141. [PMC free article] [PubMed] [Google Scholar]
  9. Dasgupta G., Momand J. Geldanamycin prevents nuclear translocation of mutant p53. Exp Cell Res. 1997 Nov 25;237(1):29–37. doi: 10.1006/excr.1997.3766. [DOI] [PubMed] [Google Scholar]
  10. Delphin C., Cahen P., Lawrence J. J., Baudier J. Characterization of baculovirus recombinant wild-type p53. Dimerization of p53 is required for high-affinity DNA binding and cysteine oxidation inhibits p53 DNA binding. Eur J Biochem. 1994 Jul 15;223(2):683–692. doi: 10.1111/j.1432-1033.1994.tb19041.x. [DOI] [PubMed] [Google Scholar]
  11. Dumaz N., Meek D. W. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J. 1999 Dec 15;18(24):7002–7010. doi: 10.1093/emboj/18.24.7002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Finlay C. A., Hinds P. W., Tan T. H., Eliyahu D., Oren M., Levine A. J. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol. 1988 Feb;8(2):531–539. doi: 10.1128/mcb.8.2.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gaiddon C., Moorthy N. C., Prives C. Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J. 1999 Oct 15;18(20):5609–5621. doi: 10.1093/emboj/18.20.5609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Giaccia A. J., Kastan M. B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 1998 Oct 1;12(19):2973–2983. doi: 10.1101/gad.12.19.2973. [DOI] [PubMed] [Google Scholar]
  15. Gu W., Roeder R. G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 1997 Aug 22;90(4):595–606. doi: 10.1016/s0092-8674(00)80521-8. [DOI] [PubMed] [Google Scholar]
  16. Gudas J., Nguyen H., Li T., Hill D., Cowan K. H. Effects of cell cycle, wild-type p53 and DNA damage on p21CIP1/Waf1 expression in human breast epithelial cells. Oncogene. 1995 Jul 20;11(2):253–261. [PubMed] [Google Scholar]
  17. Hainaut P., Milner J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res. 1993 Oct 1;53(19):4469–4473. [PubMed] [Google Scholar]
  18. Jayaraman L., Murthy K. G., Zhu C., Curran T., Xanthoudakis S., Prives C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev. 1997 Mar 1;11(5):558–570. doi: 10.1101/gad.11.5.558. [DOI] [PubMed] [Google Scholar]
  19. Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991 Dec 1;51(23 Pt 1):6304–6311. [PubMed] [Google Scholar]
  20. Kastan M. B., Zhan Q., el-Deiry W. S., Carrier F., Jacks T., Walsh W. V., Plunkett B. S., Vogelstein B., Fornace A. J., Jr A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 1992 Nov 13;71(4):587–597. doi: 10.1016/0092-8674(92)90593-2. [DOI] [PubMed] [Google Scholar]
  21. Kern S. E., Kinzler K. W., Bruskin A., Jarosz D., Friedman P., Prives C., Vogelstein B. Identification of p53 as a sequence-specific DNA-binding protein. Science. 1991 Jun 21;252(5013):1708–1711. doi: 10.1126/science.2047879. [DOI] [PubMed] [Google Scholar]
  22. Lii C. K., Chai Y. C., Zhao W., Thomas J. A., Hendrich S. S-thiolation and irreversible oxidation of sulfhydryls on carbonic anhydrase III during oxidative stress: a method for studying protein modification in intact cells and tissues. Arch Biochem Biophys. 1994 Jan;308(1):231–239. doi: 10.1006/abbi.1994.1033. [DOI] [PubMed] [Google Scholar]
  23. Liu L., Scolnick D. M., Trievel R. C., Zhang H. B., Marmorstein R., Halazonetis T. D., Berger S. L. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol. 1999 Feb;19(2):1202–1209. doi: 10.1128/mcb.19.2.1202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ljungman M., Zhang F., Chen F., Rainbow A. J., McKay B. C. Inhibition of RNA polymerase II as a trigger for the p53 response. Oncogene. 1999 Jan 21;18(3):583–592. doi: 10.1038/sj.onc.1202356. [DOI] [PubMed] [Google Scholar]
  25. Maltzman W., Czyzyk L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol. 1984 Sep;4(9):1689–1694. doi: 10.1128/mcb.4.9.1689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Miller R. M., Sies H., Park E. M., Thomas J. A. Phosphorylase and creatine kinase modification by thiol-disulfide exchange and by xanthine oxidase-initiated S-thiolation. Arch Biochem Biophys. 1990 Feb 1;276(2):355–363. doi: 10.1016/0003-9861(90)90732-e. [DOI] [PubMed] [Google Scholar]
  27. Moll U. M., Ostermeyer A. G., Haladay R., Winkfield B., Frazier M., Zambetti G. Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Mol Cell Biol. 1996 Mar;16(3):1126–1137. doi: 10.1128/mcb.16.3.1126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Nobel C. I., Kimland M., Lind B., Orrenius S., Slater A. F. Dithiocarbamates induce apoptosis in thymocytes by raising the intracellular level of redox-active copper. J Biol Chem. 1995 Nov 3;270(44):26202–26208. doi: 10.1074/jbc.270.44.26202. [DOI] [PubMed] [Google Scholar]
  29. Park E. M., Thomas J. A. S-thiolation of creatine kinase and glycogen phosphorylase b initiated by partially reduced oxygen species. Biochim Biophys Acta. 1988 Feb 17;964(2):151–160. doi: 10.1016/0304-4165(88)90161-4. [DOI] [PubMed] [Google Scholar]
  30. Pearson G. D., Merrill G. F. Deletion of the Saccharomyces cerevisiae TRR1 gene encoding thioredoxin reductase inhibits p53-dependent reporter gene expression. J Biol Chem. 1998 Mar 6;273(10):5431–5434. doi: 10.1074/jbc.273.10.5431. [DOI] [PubMed] [Google Scholar]
  31. Rainwater R., Parks D., Anderson M. E., Tegtmeyer P., Mann K. Role of cysteine residues in regulation of p53 function. Mol Cell Biol. 1995 Jul;15(7):3892–3903. doi: 10.1128/mcb.15.7.3892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sakaguchi K., Herrera J. E., Saito S., Miki T., Bustin M., Vassilev A., Anderson C. W., Appella E. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 1998 Sep 15;12(18):2831–2841. doi: 10.1101/gad.12.18.2831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Shieh S. Y., Ikeda M., Taya Y., Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell. 1997 Oct 31;91(3):325–334. doi: 10.1016/s0092-8674(00)80416-x. [DOI] [PubMed] [Google Scholar]
  34. Stamler J. S., Toone E. J., Lipton S. A., Sucher N. J. (S)NO signals: translocation, regulation, and a consensus motif. Neuron. 1997 May;18(5):691–696. doi: 10.1016/s0896-6273(00)80310-4. [DOI] [PubMed] [Google Scholar]
  35. Sun Y., Oberley L. W. Redox regulation of transcriptional activators. Free Radic Biol Med. 1996;21(3):335–348. doi: 10.1016/0891-5849(96)00109-8. [DOI] [PubMed] [Google Scholar]
  36. Takasawa T., Onodera M., Shiokawa H. Properties of three creatine kinases MM from porcine skeletal muscle. J Biochem. 1983 Feb;93(2):389–395. doi: 10.1093/oxfordjournals.jbchem.a134192. [DOI] [PubMed] [Google Scholar]
  37. Thomas J. A., Poland B., Honzatko R. Protein sulfhydryls and their role in the antioxidant function of protein S-thiolation. Arch Biochem Biophys. 1995 May 10;319(1):1–9. doi: 10.1006/abbi.1995.1261. [DOI] [PubMed] [Google Scholar]
  38. Thomas J. A., Zhao W., Hendrich S., Haddock P. Analysis of cells and tissues for S-thiolation of specific proteins. Methods Enzymol. 1995;251:423–429. doi: 10.1016/0076-6879(95)51145-8. [DOI] [PubMed] [Google Scholar]
  39. Ueno M., Masutani H., Arai R. J., Yamauchi A., Hirota K., Sakai T., Inamoto T., Yamaoka Y., Yodoi J., Nikaido T. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem. 1999 Dec 10;274(50):35809–35815. doi: 10.1074/jbc.274.50.35809. [DOI] [PubMed] [Google Scholar]
  40. Verhaegh G. W., Richard M. J., Hainaut P. Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper. Mol Cell Biol. 1997 Oct;17(10):5699–5706. doi: 10.1128/mcb.17.10.5699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Vile G. F., Rothwell L. A., Kettle A. J. Hypochlorous acid activates the tumor suppressor protein p53 in cultured human skin fibroblasts. Arch Biochem Biophys. 1998 Nov 1;359(1):51–56. doi: 10.1006/abbi.1998.0881. [DOI] [PubMed] [Google Scholar]
  42. Wild A. C., Mulcahy R. T. Pyrrolidine dithiocarbamate up-regulates the expression of the genes encoding the catalytic and regulatory subunits of gamma-glutamylcysteine synthetase and increases intracellular glutathione levels. Biochem J. 1999 Mar 15;338(Pt 3):659–665. [PMC free article] [PubMed] [Google Scholar]
  43. Wu H. H., Momand J. Pyrrolidine dithiocarbamate prevents p53 activation and promotes p53 cysteine residue oxidation. J Biol Chem. 1998 Jul 24;273(30):18898–18905. doi: 10.1074/jbc.273.30.18898. [DOI] [PubMed] [Google Scholar]
  44. Zambetti G. P., Bargonetti J., Walker K., Prives C., Levine A. J. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev. 1992 Jul;6(7):1143–1152. doi: 10.1101/gad.6.7.1143. [DOI] [PubMed] [Google Scholar]
  45. el-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993 Nov 19;75(4):817–825. doi: 10.1016/0092-8674(93)90500-p. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES